← Back to Analyst Consensus 
FULC Hold
Fulcrum Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 11
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Oct 29, 2026 (3 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jun 3, 2026 | JP Morgan | downgrade | Overweight → Underweight | — | 55% |
| Jun 2, 2026 | Stifel | downgrade | Buy → Hold | — | 53% |
| Jun 2, 2026 | Piper Sandler | downgrade | Overweight → Underweight | — | 54% |
| Jun 2, 2026 | Truist Securities | downgrade | Buy → Hold | — | 54% |
| Jun 2, 2026 | Leerink Partners | downgrade | Outperform → Market Perform | — | 51% |
| Jun 2, 2026 | HC Wainwright & Co. | downgrade | Buy → Neutral | — | 44% |
| Jan 12, 2026 | JP Morgan | initiate | — → Overweight | $20 | 55% |
| Dec 11, 2025 | Truist Securities | maintain | Buy → Buy | $18 | 54% |
| Dec 9, 2025 | B of A Securities | maintain | Underperform → Underperform | $7 | 53% |
| Dec 8, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $10 | 55% |
| Dec 8, 2025 | Cantor Fitzgerald | maintain | Overweight → Overweight | $24 | 50% |
| Dec 8, 2025 | Piper Sandler | reiterate | Overweight → Overweight | $23 | 54% |
| Dec 8, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $25 | 44% |
| Nov 24, 2025 | Truist Securities | initiate | — → Buy | $14 | 54% |
| Nov 24, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $18 | 44% |
| Oct 30, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $7 | 55% |
| Oct 30, 2025 | Piper Sandler | reiterate | Overweight → Overweight | $16 | 54% |
| Oct 20, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Jul 30, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $5 | 55% |
| Jul 29, 2025 | HC Wainwright & Co. | upgrade | Neutral → Buy | $12 | 44% |
| May 29, 2025 | Piper Sandler | maintain | Overweight → Overweight | $9 | 54% |
| May 23, 2025 | Leerink Partners | upgrade | Market Perform → Outperform | $12 | 51% |
| May 15, 2025 | Cantor Fitzgerald | upgrade | Neutral → Overweight | $10 | 50% |
| Feb 26, 2025 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $4 | 44% |
| Nov 14, 2024 | RBC Capital | reiterate | Sector Perform → Sector Perform | $4 | 55% |
| Nov 14, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $4 | 44% |
| Sep 13, 2024 | RBC Capital | downgrade | Outperform → Sector Perform | $4 | 55% |
| Sep 13, 2024 | HC Wainwright & Co. | downgrade | Buy → Neutral | $4 | 44% |
| Sep 12, 2024 | Leerink Partners | downgrade | Outperform → Market Perform | $4 | 51% |
| Sep 12, 2024 | B of A Securities | downgrade | Neutral → Underperform | $2 | 53% |
| Sep 12, 2024 | Stifel | downgrade | Buy → Hold | $3 | 53% |
| Sep 12, 2024 | Cantor Fitzgerald | downgrade | Overweight → Neutral | $0 | 50% |
| Sep 9, 2024 | B of A Securities | upgrade | Underperform → Neutral | $10 | 53% |
| Aug 1, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $17 | 44% |
| Jul 10, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $23 | 50% |
| May 20, 2024 | Cantor Fitzgerald | initiate | — → Overweight | $23 | 50% |
| May 14, 2024 | Goldman Sachs | upgrade | Neutral → Buy | $15 | 54% |
| May 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $17 | 44% |
| May 14, 2024 | Oppenheimer | maintain | Outperform → Outperform | $14 | 52% |
| May 13, 2024 | Goldman Sachs | upgrade | Neutral → Buy | $15 | 54% |
| Mar 13, 2024 | RBC Capital | initiate | — → Outperform | $14 | 55% |
| Feb 28, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $17 | 44% |
| Feb 28, 2024 | Piper Sandler | maintain | Overweight → Overweight | $15 | 54% |
| Jan 26, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $6 | 54% |
| Jan 25, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $6 | 54% |
| Sep 25, 2023 | Goldman Sachs | initiate | — → Neutral | $5 | 54% |
| Aug 23, 2023 | HC Wainwright & Co. | upgrade | Neutral → Buy | $14 | 44% |
| Aug 22, 2023 | Oppenheimer | reiterate | Outperform → Outperform | $16 | 52% |
| Aug 22, 2023 | Stifel | upgrade | Hold → Buy | $11 | 53% |
| Aug 4, 2023 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $5 | 44% |
Price Target Trend
Apr 24, 2026 Oct 26, 2026
EPS Estimates
+1q —
0q —
0y —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days